The associations of plasma KIM-1 levels with kidney outcomes in our study, in whom the vast majority of patients had chronic kidney disease stage 1 or 2, suggest that fibrosis is involved in kidney disease progression even when kidney function is relatively preserved. This evidence concerns the gene HAVCR1 and kidney disorder.